1. The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase. Clin Mol Hepatol 2023 (In eng). DOI: 10.3350/cmh.2022.0322.
2. Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL. Am J Gastroenterol 2022;117(2):288-294. (In eng). DOI: 10.14309/ajg.0000000000001497.
3. Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial. PLoS One 2022;17(7):e0270716. (In eng). DOI: 10.1371/journal.pone.0270716.
4. Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19. Diagnostics (Basel) 2022;12(9) (In eng). DOI: 10.3390/diagnostics12092255.
5. Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma. Genes (Basel) 2022;13(8) (In eng). DOI: 10.3390/genes13081484.
6. A Case of Hepatic Immunoglobulin G4-Related Disease Presenting as an Inflammatory Pseudotumor and Sclerosing Cholangitis. Diagnostics (Basel) 2022;12(6) (In eng). DOI: 10.3390/diagnostics12061497.
7. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. J Exp Clin Cancer Res 2022;41(1):98. (In eng). DOI: 10.1186/s13046-022-02296-3.
8. Deep Learning-Based Four-Region Lung Segmentation in Chest Radiography for COVID-19 Diagnosis. Diagnostics (Basel) 2022;12(1) (In eng). DOI: 10.3390/diagnostics12010101.
9. Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients. J Korean Med Sci 2021;36(16):e105. (In eng). DOI: 10.3346/jkms.2021.36.e105.
10. Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma. Sci Rep 2021;11(1):14930. (In eng). DOI: 10.1038/s41598-021-94074-y.
11. Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver. Diagnostics (Basel) 2021;11(6) (In eng). DOI: 10.3390/diagnostics11061061.
12. Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment. Gut Liver 2021;15(4):606-615. (In eng). DOI: 10.5009/gnl20267.
13. Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma. Medicine (Baltimore) 2021;100(16):e25552. (In eng). DOI: 10.1097/md.0000000000025552.
14. Federated learning for predicting clinical outcomes in patients with COVID-19. Nat Med 2021;27(10):1735-1743. (In eng). DOI: 10.1038/s41591-021-01506-3.
15. A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records. Eur J Radiol 2021;139:109583. (In eng). DOI: 10.1016/j.ejrad.2021.109583.
16. Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19. Med Image Anal 2021;70:101993. (In eng). DOI: 10.1016/j.media.2021.101993.
17. Severity and Consolidation Quantification of COVID-19 From CT Images Using Deep Learning Based on Hybrid Weak Labels. IEEE J Biomed Health Inform 2020;24(12):3529-3538. (In eng). DOI: 10.1109/jbhi.2020.3030224.
18. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Ann Lab Med 2021;41(3):302-309. (In eng). DOI: 10.3343/alm.2021.41.3.302.
19. Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir. J Viral Hepat 2021;28(1):95-104. (In eng). DOI: 10.1111/jvh.13411.
20. Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation. Eur J Radiol Open 2020;7:100300. (In eng). DOI: 10.1016/j.ejro.2020.100300.
21. Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study. BMJ Open 2020;10(11):e041989. (In eng). DOI: 10.1136/bmjopen-2020-041989.
22. Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. Life (Basel) 2020;10(10) (In eng). DOI: 10.3390/life10100230.
23. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clin Mol Hepatol 2020;26(4):562-576. (In eng). DOI: 10.3350/cmh.2020.0126.
24. Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Genes (Basel) 2020;11(5) (In eng). DOI: 10.3390/genes11050545.
25. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study. Nutrients 2020;12(5) (In eng). DOI: 10.3390/nu12051429.
26. Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study. Cancer Epidemiol Biomarkers Prev 2020;29(4):832-837. (In eng). DOI: 10.1158/1055-9965.Epi-19-0614.
27. Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma. Gut Liver 2020;14(4):500-508. (In eng). DOI: 10.5009/gnl19155.
28. Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy. Clin Gastroenterol Hepatol 2020;18(3):693-699.e1. (In eng). DOI: 10.1016/j.cgh.2019.06.028.
29. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea. Journal of hepatology 2019;71:456-64.
30. Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019.
31. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis. Clin Gastroenterol Hepatol 2018;16:1954-1963.e1953.
32. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial. Am J Gastroenterol 2018;113:1167-1176.
33. Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma. Biomark Med 2018;12:1105-1114.
34. Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation. Eur J Gastroenterol Hepatol 2018;30:1230-1236.
35. Lee YR, Kim G, Tak WY, et al. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. International journal of cancer 2018.
36. Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B. Dig Liver Dis 2018;50:163-167.
37. Survival estimates after stopping sorafenib in patients with hepatocellular carcinoma: NEXT Score development and validation. Gut and liver 2017;11:693.
38. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. Clin Radiol 2017;72:692.e699-692.e615.
39. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study. Medicine (Baltimore) 2017;96:e6580.
40. Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report. Oncol Lett 2017;14:4853-4856.
41. Clinical significance of lncRNA-ATB expression in human hepatocellular carcinoma. Oncotarget 2017;8:78588-78597.
42. Small Bowel Perforation after Percutaneous Ultrasound-guided Radiofrequency Ablation of Hepatocellular Carcinoma. Clinical Ultrasound 2017;2:68-72.
43. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol 2017;32:1079-1086.
44. Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension. Hepatology 2015;61:1033-1040.
45. Clinical outcomes of argon plasma coagulation therapy for early gastric neoplasms. Clin Endosc 2015;48:147-151.
46. P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma. Clin Mol Hepatol 2015;21:230-231.
47. Spontaneous rupture of eosinophilic liver abscess. Eur J Gastroenterol Hepatol 2014;26:1440-1443.
48. Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients. Clinical and molecular hepatology 2013;19:148.